CRIS Current Research Information System

MASETTI, RICCARDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.895
EU - Europa 6.544
AS - Asia 4.828
AF - Africa 350
SA - Sud America 59
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 4
Totale 20.691
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.849
CN - Cina 1.793
IT - Italia 1.586
GB - Regno Unito 1.459
SG - Singapore 1.202
DE - Germania 948
SE - Svezia 711
VN - Vietnam 632
HK - Hong Kong 478
IN - India 368
RU - Federazione Russa 356
FR - Francia 303
IE - Irlanda 280
UA - Ucraina 176
NL - Olanda 155
KR - Corea 150
FI - Finlandia 130
ZA - Sudafrica 120
CI - Costa d'Avorio 97
TG - Togo 96
EE - Estonia 89
BG - Bulgaria 74
CH - Svizzera 60
ID - Indonesia 60
AT - Austria 58
JO - Giordania 48
PL - Polonia 40
BR - Brasile 34
CA - Canada 30
BE - Belgio 29
NG - Nigeria 24
GR - Grecia 22
TR - Turchia 22
ES - Italia 18
MX - Messico 14
JP - Giappone 13
DK - Danimarca 11
LB - Libano 11
AU - Australia 9
HR - Croazia 9
IL - Israele 9
IR - Iran 9
RO - Romania 9
CL - Cile 7
SC - Seychelles 7
MY - Malesia 6
AR - Argentina 5
BD - Bangladesh 5
CO - Colombia 5
LT - Lituania 5
PE - Perù 5
A2 - ???statistics.table.value.countryCode.A2??? 4
CZ - Repubblica Ceca 4
UZ - Uzbekistan 4
MD - Moldavia 3
PK - Pakistan 3
PT - Portogallo 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
EC - Ecuador 2
EG - Egitto 2
ET - Etiopia 2
GH - Ghana 2
HU - Ungheria 2
NZ - Nuova Zelanda 2
PH - Filippine 2
SI - Slovenia 2
SV - El Salvador 2
TW - Taiwan 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
IQ - Iraq 1
KG - Kirghizistan 1
KW - Kuwait 1
LK - Sri Lanka 1
NO - Norvegia 1
TM - Turkmenistan 1
Totale 20.691
Salva come PNG Salva come JPEG
Città #
Southend 1.311
Fairfield 1.118
Singapore 1.027
Ashburn 948
Chandler 747
Woodbridge 541
Seattle 508
Wilmington 490
Santa Clara 487
Hong Kong 461
Houston 418
Cambridge 403
Bologna 400
Princeton 389
Ann Arbor 311
Dublin 280
Dong Ket 257
Boardman 240
Hefei 190
Nanjing 157
Seoul 138
Westminster 133
Padova 123
Milan 106
Berlin 99
Beijing 98
Abidjan 97
Lomé 96
Jinan 89
Frankfurt am Main 86
Helsinki 82
New York 79
San Diego 74
Sofia 71
Shenyang 67
Turin 59
Saint Petersburg 58
Ho Chi Minh City 57
Jacksonville 56
Jakarta 56
Munich 56
Mülheim 55
Rome 52
Hanoi 50
Shanghai 49
Amman 48
Changsha 48
Bern 47
Bremen 47
Guangzhou 46
Redmond 46
Nanchang 43
Hebei 42
Los Angeles 40
Dearborn 36
Nuremberg 36
Tianjin 36
Zhengzhou 36
Medford 35
Redwood City 32
Des Moines 31
Brussels 29
Vicenza 29
Vienna 28
Lappeenranta 27
Falkenstein 25
Norwalk 25
Abeokuta 23
Hangzhou 23
London 23
Ningbo 23
Tongling 23
Jiaxing 22
Paris 22
Yubileyny 21
Council Bluffs 20
Fuzhou 19
Haikou 19
Olalla 19
Turku 19
Wuhan 19
Phoenix 18
Taizhou 18
Bühl 17
Düsseldorf 17
Forlì 17
Kuban 17
Chengdu 16
Chicago 15
Xi'an 15
Ravenna 14
Falls Church 13
Moscow 13
Shenzhen 13
Shijiazhuang 13
Taiyuan 13
Verona 13
Ferrara 12
Florence 12
Harbin 12
Totale 14.054
Salva come PNG Salva come JPEG
Nome #
Acute myeloid leukemia in infants: biology and treatment 202
A New Formulation of an Old Drug: A Potential New Therapy in the Management of Oral cGvHD 186
Central nervous system complications in children receiving chemotherapy or hematopoietic stem cell transplantation 186
Identification of the NUP98-PHF23 fusion gene in pediatric cytogenetically normal acute myeloid leukemia by whole-transcriptome sequencing 185
Hh/Gli antagonist in acute myeloid leukemia with CBFA2T3-GLIS2 fusion gene 178
Early gut microbiota signature of aGvHD in children given allogeneic hematopoietic cell transplantation for hematological disorders 178
COMBINING DOT1L INHIBITOR EPZ-5676 WITH SORAFENIB TO TREAT MLL-REARRANGED (MLL-R) PEDIATRIC ACUTE MYELOID LEUKEAMIA (AML) 169
A novel specific signature of pediatric MOZ-CBP acute myeloid leukemia. 166
Benign hepatic nodular lesions after treatment for childhood cancer 162
Levofloxacin prophylaxis and parenteral nutrition have a detrimental effect on intestinal microbial networks in pediatric patients undergoing HSCT 159
All-trans retinoic acid in the treatment of pediatric acute promyelocytic leukemia. 158
t(6;9)(p22;q34)/DEK-NUP214 rearranged pediatric myeloid leukemia: an international study on 62 patients. 156
25-hydroxyvitamin D deficiency and bone mineral density alterations in paediatric patients who underwent haematopoietic stem cell transplantation 152
CBFA2T3-GLIS2 fusion transcript is a novel common feature in pediatric, cytogenetically normal AML, not restricted to FAB M7 subtype. 151
Genomic complexity and dynamics of clonal evolution in childhood acute myeloid leukemia studied with whole-exome sequencing 148
Occurrence of Albifimbria verrucaria in the Blood of a Female Child With Neuroblastoma 147
Autoimmune polyglandular syndrome type III after haploidentical hematopoietic stem cell transplantation in a child with acute myeloid leukemia. 145
CBFA2T3-GLIS2-positive acute myeloid leukaemia. A peculiar paediatric entity 145
Gut resistome plasticity in pediatric patients undergoing hematopoietic stem cell transplantation 145
Associazione Italiana di Ematologia ed Oncoematologia Pediatrica : Linee Guida per la profilassi ed il trattamento della sindrome da lisi tumorale 144
4118 Clofarabine: safety and efficacy profile for treatment of pediatric patients with refractory or relapsed acute leukemias 143
Fecal microbiota transplantation in allogeneic hematopoietic stem cell transplantation recipients: A systematic review 141
Protocollo AIEOP LAM 2002/01 : risultati preliminari 140
Life-threatening complications of posterior reversible encephalopathy syndrome in children 138
Risk factor analysis of posterior reversible encephalopathy syndrome after allogeneic hematopoietic SCT in children 137
COMBINAZIONE DI EPZ-5676 E SORAFENIB COME NUOVA STRATEGIA TERAPEUTICA PER IL TRATTAMENTO DELLE LEUCEMIE ACUTE MIELOIDI PEDIATRICHE 137
Emerging targeted therapies for pediatric acute myeloid leukemia. 136
Focal nodular hyperplasia of the liver after intensive treatment for pediatric cancer: is hematopoietic stem cell transplantation a risk factor? 135
PRES in children undergoing hematopoietic stem cell or solid organ transplantation 133
Enteral nutrition protects children undergoing allogeneic hematopoietic stem cell transplantation from blood stream infections 133
Clinical effectiveness of early treatment with hyperbaric oxygen therapy for severe late-onset hemorrhagic cystitis after hematopoietic stem cell transplantation in pediatric patients. 132
Characterization of children with FLT3-ITD acute myeloid leukemia: A report from the AIEOP AML-2002 study group 132
Unbalance of intestinal microbiota in atopic children 131
MYCN is a novel oncogenic target in pediatric T-cell Acute Lymphoblastic Leukemia 131
Use of clofarabine for acute childhood leukemia. 130
Gut microbiota diversity before allogeneic hematopoietic stem cell transplantation as predictor of mortality in children 129
Anterior Mediastinal Tumors 129
Focal nodular hyperplasia of the liver in children after hematopoietic stem cell transplantation. 129
Computed Tomography in Acute Severe Central Nervous System Complications in Children Treated for Cancer: Still a Useful Diagnostic Tool in the Emergency Setting 129
Immune response against adenovirus in acute upper respiratory tract infections in immunocompetent children 129
Status epilepticus as a main manifestation of posterior reversible encephalopathy syndrome after pediatric hematopoietic stem cell transplantation 125
LIN28B overexpression defines a novel fetal-like subgroup of juvenile myelomonocytic leukemia 125
Bridging to transplant with azacitidine in juvenile myelomonocytic leukemia: A retrospective analysis of the EWOG-MDS study group 124
Usefulness of liver stiffness measurement in predicting hepatic veno-occlusive disease development in patients who undergo HSCT 123
Impact of inflammatory cytokine gene polymorphisms on developing acute graft-versus-host disease in children undergoing allogeneic hematopoietic stem cell transplantation 122
Enteral Nutrition in Pediatric Patients Undergoing Hematopoietic SCT Promotes the Recovery of Gut Microbiome Homeostasis 122
Minimal residual disease monitored after induction therapy by rq-pcr can contribute to tailor treatment of patients with t(8;21) runx1-runx1t1 rearrangement 121
Two Cases of Abdominal Pain in Children with Mesenteric Lymphadenitis due to Yersinia pseudotuberculosis Infection. 120
null 120
The changing scenario of non-Down syndrome acute megakaryoblastic leukemia in children 120
Retinoids in pediatric onco-hematology: the model of acute promyelocytic leukemia and neuroblastoma. 119
Granulocytic sarcoma of the knee and the spine as aleukemic relapse of acute myeloid leukemia in a child. 119
BAG1 Overexpression Restrains the Anti-Apoptotic BCL2, MCL1 and HSP70 Proteins in Acute Myeloid Leukemia 118
Outcome of children with high-risk acute myeloid leukemia given autologous or allogeneic hematopoietic cell transplantation in the aieop AML-2002/01 study 118
Allogeneic Hematopoietic Stem Cell Transplantation for Philadelphia-Positive Acute Lymphoblastic Leukemia in Children and Adolescents: A Retrospective Multicenter Study of the Italian Association of Pediatric Hematology and Oncology (AIEOP) 117
Gut microbiota and hematopoietic stem cell transplantation: where do we stand? 117
Hematopoietic stem cell transplantation for curing children with severe autoimmune diseases: is this a valid option? 116
DHH-RHEBL1 fusion transcript: a novel recurrent feature in the new landscape of pediatric CBFA2T3-GLIS2-positive acute myeloid leukemia. 116
NUP98-fusion transcripts characterize different biological entities within acute myeloid leukemia: A report from the AIEOP-AML group 115
null 114
Outcome of children with acute myeloid leukaemia (AML) experiencing primary induction failure in the AIEOP AML 2002/01 clinical trial 113
Successes and Challenges for Diagnosis and Therapy of Acute Leukemia 113
Necrotizing Enterocolitis: Overview on In Vitro Models 112
FLAG-liposomal doxorubicin (Myocet) regimen for refractory or relapsed acute leukemia pediatric patients. 111
NUCLEOPHOSMIN MUTATIONS IN CHILDHOOD ACUTE MYELOGENOUS LEUKEMIA WITH NORMAL KARYOTYPE. 110
First-line treatment of acute lymphoblastic leukemia with pegasparaginase. 110
Mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia: A report from the italian AIEOP study group 110
Infants with acute myeloid leukemia treated according to the Associazione Italiana di Ematologia e Oncologia Pediatrica 2002/01 protocol have an outcome comparable to that of older children. 110
Perfluoroalkyl substances in human milk: A first survey in Italy 109
Early modifications of the gut microbiome in children with hepatic sinusoidal obstruction syndrome after hematopoietic stem cell transplantation 109
Enteral versus Parenteral Nutrition as Nutritional Support after Allogeneic Hematopoietic Stem Cell Transplantation: a Systematic Review and Meta-Analysis 108
Risultati del protocollo AIEOP LAM 2002/01 per la diagnosi e terapia delle leucemie acute mieloidi pediatriche 107
Targeting Hedgehog pathway in pediatric acute myeloid leukemia: challenges and opportunities 107
Insights on the Interplay between Cells Metabolism and Signaling: A Therapeutic Perspective in Pediatric Acute Leukemias 107
The altered transcriptome of pediatric myelodysplastic syndrome revealed by RNA sequencing 107
Mutazioni del gene NPM identificano un sottogruppo di pazienti pediatrici con leucemia acuta mieloide e cariotipo normale;un nuovo marcatore di malattia residua minima 106
Pediatric early T-cell precursor leukemia with NF1 deletion and high-sensitivity in vitro to tipifarnib. 106
Inhibition of methyltransferase dot1l sensitizes to sorafenib treatment aml cells irrespective of mll-rearrangements: A novel therapeutic strategy for pediatric aml 106
The impact of large sections on the study of in situ and invasive carcinoma of the breast. 105
Prognostic significance of flow-cytometry evaluation of minimal residual disease in children with acute myeloid leukaemia treated according to the AIEOP-AML 2002/01 study protocol 105
Posterior Reversible Encephalopathy Syndrome in infants and young children 105
Autoimmune hemolytic anemia in children with COVID-19 104
Precoce predittività di attecchimento midollare dopo trapianto allogenico di cellule staminali emopoietiche in pazienti pediatrici mediante valutazione del chimerismo emopoietico con metodo multiplex polymerase chain reaction 103
Expanding phenotype of schimke immuno-osseous dysplasia: Congenital anomalies of the kidneys and of the urinary tract and alteration of nk cells 103
Juvenile arthritis after haematopoietic stem cell transplantation. 102
HLA-mismatched hematopoietic stem cell tranplantation for pediatric solid tumors. 101
Personalized Medicine for Pediatric AML: New Targeted StrategiesTopics in Anti-Cancer Research 99
Targeting BAG-1: A novel strategy to increase drug efficacy in acute myeloid leukemia 99
Gata2 related conditions and predisposition to pediatric myelodysplastic syndromes 99
Allogeneic hematopoietic stem cell transplantation for pediatric acute myeloid leukemia in first complete remission: a meta-analysis 98
Inflammatory disease of the central nervous system induced by anti-GD2 monoclonal antibody in a patient with high risk neuroblastoma. 98
MicroRNA fingerprints in juvenile myelomonocytic leukemia (JMML) identified miR-150-5p as a tumor suppressor and potential target for treatment 98
Etiology, characteristics and outcome of seizures after pediatric hematopoietic stem cell transplantation 96
Immune dysregulation associated with co-occurring germline CBL and SH2B3 variants 95
Febrile Neutropenia Duration Is Associated with the Severity of Gut Microbiota Dysbiosis in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients 95
Monitoraggio preliminare sulla presenza di composti perfluorurati in latte vaccino italiano 95
MicroRNA-34b promoter hypermethylation induces CREB overexpression and contributes to myeloid transformation. 95
The role of HDACs inhibitors in childhood and adolescence acute leukemias. 95
DNA methyltransferase 3a hot-spot locus is not mutated in pediatric patients affected by acute myeloid or T-cell acute lymphoblastic leukemia: an Italian study. 94
Criteria for evaluating response and outcome in clinical trials for children with juvenile myelomonocytic leukemia 94
Totale 12.466
Salva come PNG Salva come JPEG
Categoria #
all - tutte 68.870
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.870
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.424 399 277 132 86 186 100 63 111 221 127 107 615
2021/20222.950 243 79 162 213 289 202 104 262 163 152 603 478
2022/20233.437 435 493 240 415 204 216 138 208 551 97 300 140
2023/20241.163 63 146 143 140 76 209 59 65 52 92 50 68
2024/20255.715 244 791 570 312 832 293 600 205 134 346 337 1.051
2025/2026506 506 0 0 0 0 0 0 0 0 0 0 0
Totale 21.303